Abstract
This study evaluated a long-acting injectable (LAI) treatment program through examining the short and long-term outcomes of patients with schizophrenia or schizoaffective disorders receiving the LAI treatment in comparison with those receiving oral antipsychotic medications. Our findings provide insight into patient demographics, hospitalization rates, total medications, and dose ratios.
Sigma Membership
Eta
Lead Author Affiliation
University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Type
Poster
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Long-Acting Injectable Antipsychotic Medications, Patient Outcomes, Schizophrenia and Schizoaffective Disorders
Recommended Citation
Lee, Heeyoung and Lu, Lin, "Examining patient outcomes of receiving long-acting injectable antipsychotics" (2019). INRC (Congress). 305.
https://www.sigmarepository.org/inrc/2019/posters_2019/305
Conference Name
30th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Calgary, Alberta, Canada
Conference Year
2019
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Examining patient outcomes of receiving long-acting injectable antipsychotics
Calgary, Alberta, Canada
This study evaluated a long-acting injectable (LAI) treatment program through examining the short and long-term outcomes of patients with schizophrenia or schizoaffective disorders receiving the LAI treatment in comparison with those receiving oral antipsychotic medications. Our findings provide insight into patient demographics, hospitalization rates, total medications, and dose ratios.